TriLink BioTechnologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TriLink BioTechnologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11485
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TriLink BioTechnologies Inc (TriLink), a subsidiary of Maravai Life Sciences Inc, is a manufacturer of modified nucleic acid products. The company’s products include oligonucleotides, nucleotides, custom chemistry, DNA synthesis reagents, cleanamp PCR products, modified nucleoside triphosphates, phosphoramidites, conjugation reagaents, mRNA and long RNA, among others. It also provides modified compounds such as aminoallyl, biotin, and two fluoro nucleotides. TriLink provides services to researchers in the areas of gene therapy, nucleoside chemotherapy, oligonucleotide therapy and diagnostics. Its products are used in research, diagnostics and therapeutic applications. The company markets its products through its distributors in Canada, Sweden, Belgium, Italy, France, the Netherlands, Germany, the UK, Ireland, Denmark, Finland, Norway and Sweden, the Czech Republic, China, Korea, Japan and Taiwan. TriLink is headquartered in San Diego, California, the US.

TriLink BioTechnologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TriLink BioTechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
TriLink BioTech Enters into Distribution Agreement with inVentis 10
TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 11
Licensing Agreements 12
TriLink BioTech Enters Into Licensing Agreement With QuantiBact 12
TriLink BioTechnologies Enters Into Licensing Agreement With Li-cor Biosciences 13
TriLink BioTechnologies Inc – Key Competitors 14
TriLink BioTechnologies Inc – Key Employees 15
TriLink BioTechnologies Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Strategy And Business Planning 17
Sep 10, 2018: Maravai LifeSciences expands oligonucleotide business, leases new facility for TriLink BioTechnologies 17
Corporate Communications 18
May 01, 2018: Maravai LifeSciences Expands Top Management Team with Four New Hires 18
Nov 27, 2017: TriLink BioTechnologies Names Michael Houston As New Chief Scientific Officer 19
Other Significant Developments 20
Sep 10, 2018: Maravai LifeSciences expands oligonucleotide business, leases new facility for TriLink BioTechnologies 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TriLink BioTechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TriLink BioTech Enters into Distribution Agreement with inVentis 10
TriLink BioTechnologies Enters Into Distribution Agreement With Sigma-Aldrich 11
TriLink BioTech Enters Into Licensing Agreement With QuantiBact 12
TriLink BioTechnologies Enters Into Licensing Agreement With Li-cor Biosciences 13
TriLink BioTechnologies Inc, Key Competitors 14
TriLink BioTechnologies Inc, Key Employees 15

List of Figures
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TriLink BioTechnologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TriLink BioTechnologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[TriLink BioTechnologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arise AB (ARISE):企業の財務・戦略的SWOT分析
    Arise AB (ARISE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Korea National Oil Corporation-石油・ガス分野:企業M&A・提携分析
    Summary Korea National Oil Corporation (KNOC) is a state-owned integrated energy company that carries out the exploration, development and production of oil and gas, and stockpiling of petroleum resources. The company purchases and sells crude oil, distribute gasoline and gasoline oil and sells refi …
  • KBR Inc (KBR):石油・ガス:M&Aディール及び事業提携情報
    Summary KBR, Inc. (KBR) is a global provider of engineering, construction, and professional services and technologies. The company offers specialized engineering and design, technology licensing, program management, construction management, specialized consulting, operations, maintenance and other s …
  • Romelectro S.A.:企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • National Electric Power Co:企業の戦略的SWOT分析
    National Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Neiman Marcus Group LTD LLC:企業の戦略的SWOT分析
    Neiman Marcus Group LTD LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • In’Tech Medical SAS-医療機器分野:企業M&A・提携分析
    Summary In'Tech Medical SAS (In'Tech Medical) is a medical device company that offers surgical equipment. The company designs, develops and manufactures orthopedic implants and instruments for the healthcare sector. Its surgical instruments include benders, calipers, cervical pin distractor, angled …
  • Valero Energy Corporation (VLO)-石油・ガス分野:企業M&A・提携分析
    Summary Valero Energy Corporation (Valero) is a manufacturer and marketer of transportation fuels, petrochemical products and power. The company’s assets include petroleum refineries, ethanol plants, a wind farm and renewable diesel production from a joint venture. Its refineries produce gasoline, d …
  • Aspen Pharmacare Holdings Ltd (APN)-製薬・医療分野:企業M&A・提携分析
    Summary Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company also manufactures infant nutritionals and consumer healthcare products in selected territories. Its manufacturi …
  • Hobby Lobby Stores Inc:戦略・SWOT・企業財務分析
    Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Orsted AS (ORSTED):石油・ガス:M&Aディール及び事業提携情報
    Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conventional fuel and wind energy sources. The company also develops, constructs, owns and …
  • Qantas Airways Ltd (QAN):企業の財務・戦略的SWOT分析
    Qantas Airways Ltd (QAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Huge China Holdings Limited (428):企業の財務・戦略的SWOT分析
    Huge China Holdings Limited (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Biocartis Group NV (BCART):企業の製品パイプライン分析
    Summary Biocartis Group NV (Biocartis) operates as a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology a …
  • Clinicient Inc-医療機器分野:企業M&A・提携分析
    Summary Clinicient Inc (Clinicient) is a healthcare technology company that offers EMR management and therapy practice solutions. The company offers insight platform software that offers single system created exclusively for outpatient rehab that populates data across both the clinical and financial …
  • SBS Transit Ltd.:戦略・SWOT・企業財務分析
    SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report Summary SBS Transit Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cambridge Research Biochemicals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cambridge Research Biochemicals Ltd (CRB) is a provider of custom peptide and custom antibody producer for research activities. The company offers products such as stock peptides, peptide nucleic acid, florescent dyes, and immunological products and labeling kits. Its immunological products …
  • Taisei Corporation:企業の戦略・SWOT・財務分析
    Taisei Corporation - Strategy, SWOT and Corporate Finance Report Summary Taisei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Portola Pharmaceuticals Inc (PTLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Portola Pharmaceuticals Inc (Portola Pharmaceuticals) is a biopharmaceutical company which conducts research to develop therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. The company's products portfolio include Betrixaban, an oral once-daily Factor Xa inh …
  • Astute Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astute Medical Inc (Astute Medical) is a healthcare service provider that provides diagnostic products. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆